Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'nsc 146109 hydrochloride'

Search results for: 'nsc 146109 hydrochloride'

Items 1-10 of 48

Page
per page
  1. NSC 405020
    A4051 NSC 405020
     1 Citation
    Target: MMP
    Summary: MT1-MMP inhibitor
      insoluble in H2O; ≥11.4 mg/mL
  2. NSC 74859
    A8338 NSC 74859
     5 Citation
    Target: STAT
    Summary: Stat3 inhibitor
      insoluble in H2O; ≥18.25 mg/mL
  3. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S regulatory particle Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL
  4. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  5. KN-92 hydrochloride
    A3530 KN-92 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: Inactive derivative of KN-93,control compound
      ≥24.65 mg/mL
  6. NB-598 hydrochloride
    A3646 NB-598 hydrochloride
    Target: Squalene epoxidases
    Summary: SE inhibitor
      ≥54 mg/mL
      insoluble in H2O
  7. NPS-2143 hydrochloride
    A3667 NPS-2143 hydrochloride
    Target: Calcium-Sensing Receptors (CaSRs)
    Summary: Calcium ion-sensing receptor antagonist
      ≥44.5 mg/mL
  8. BMS345541 hydrochloride
    A3248 BMS345541 hydrochloride
    Target: IKK
    Summary: IKK inhibitor,highly selective
      insoluble in EtOH; insoluble in DMSO; ≥60 mg/mL
  9. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  10. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL

Items 1-10 of 48

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Proteasome 1 item
  3. Histone Deacetylases (HDACs) 1 item
  4. Aurora Kinases 1 item
  5. EZH2 1 item
  6. MMP 1 item
  7. Thymidine Phosphorylases 1 item
  8. DT-diaphorases 1 item
  9. GSK-3 1 item
  10. Phosphodiesterases (PDEs) 2item
  11. Hydrolase 1 item
  12. p38 1 item
  13. Nrf2 1 item
  14. GABAB Receptors 1 item
  15. Sir2-like Family Deacetylases (Sirtuins) 1 item
  16. Deubiquitinating enzymes (DUBs) 1 item
  17. STAT 1 item
  18. EGFR 2item
  19. FAK 1 item
  20. Syk 1 item
  21. HSP90 1 item
  22. AMPK 1 item
  23. Adenosine Kinases 1 item
  24. DNA Methyltransferases 1 item
  25. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  26. SGLT 1 item
  27. Pyk2 1 item
  28. 5-HT2 Receptors 2item
  29. Myosin light chain kinases (MLCKs) 1 item
  30. 5-HT3 Receptors 1 item
  31. Angiotensin-Converting Enzymes (ACEs) 1 item
  32. CK2 1 item
  33. Squalene epoxidases 2item
  34. Nampt 1 item
  35. Glutamate (Metabotropic) Group I Receptors 1 item
  36. AChE 1 item
  37. Cytidine deaminases 1 item
  38. IKK 1 item
  39. Calcium-Sensing Receptors (CaSRs) 1 item
  40. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 3item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 5item
  6. Cancer 22item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 3item
  9. Colorectal Cancer 3item
  10. Diabetes 1 item
  11. Erectile Dysfunction 1 item
  12. Glioblastoma 2item
  13. Glioma 2item
  14. Hepatocellular Carcinoma 2item
  15. Inflammatory Diseases 2item
  16. Leukemia 1 item
  17. Liver Cancer 1 item
  18. Lung Cancer 3item
  19. Mantle Cell Lymphoma 1 item
  20. Melanoma 1 item
  21. Multidrug Resistance Studies 1 item
  22. Multiple Myeloma 3item
  23. Narcolepsy 1 item
  24. Non-small Cell Lung Cancer 1 item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 4item
  27. Schizophrenia 1 item
  28. Squamous Cell Carcinoma 1 item
  29. Type 2 Diabetes 1 item